FBI Warns: Counterfeit Semaglutide
- The FBI is alerting the public to the dangers of counterfeit compounded weight loss drugs circulating in the market.
- according to a notice posted on the FBI's website,these misrepresented drugs,which are purported to contain semaglutide,have been found to contain "compounded mixtures of unknown drugs that do not...
- The potential health consequences of using these counterfeit drugs are severe. The FBI warns that the health risks of taking the "misrepresented drugs" include a range of serious...
FBI Issues Safety Warning About Counterfeit Weight Loss Drugs Containing Semaglutide
Table of Contents
- FBI Issues Safety Warning About Counterfeit Weight Loss Drugs Containing Semaglutide
- Health Risks Associated with Counterfeit Drugs
- Sources of Counterfeit Drugs
- Case Exmaple: Animal-Grade Semaglutide
- How to Protect Yourself
- Compounded Drugs: What You Need to Know
- FDA Action on Shortages and Compounding
- Ozempic and Wegovy: Approved Uses
- How Semaglutide Works
- Timeline of Restrictions on Compounded Semaglutide
- Counterfeit Semaglutide Weight Loss Drugs: what You Need to Know
- Q&A: Counterfeit Semaglutide and Weight Loss Drugs
- What is the FBI warning about counterfeit weight loss drugs?
- What are the health risks associated with counterfeit semaglutide drugs?
- Were are these counterfeit drugs being sold?
- What is semaglutide, and what are Ozempic and Wegovy approved for?
- What is “off-label” prescription?
- What is a compounded drug, and what should I know about compounded semaglutide?
- What has the FDA done regarding shortages and compounding of semaglutide drugs?
- How can I protect myself from counterfeit weight loss drugs?
- Case Example: What happened with the animal-grade semaglutide?
- Restrictions on Compounded Semaglutide
- Q&A: Counterfeit Semaglutide and Weight Loss Drugs
The FBI is alerting the public to the dangers of counterfeit compounded weight loss drugs circulating in the market. These fraudulent medications claim to contain semaglutide, the active ingredient found in popular prescription drugs like Ozempic and Wegovy, both used for weight loss.
Health Risks Associated with Counterfeit Drugs
according to a notice posted on the FBI’s website,these misrepresented drugs,which are purported to contain semaglutide,have been found to contain “compounded mixtures of unknown drugs that do not contain semaglutide,drugs with high levels of impurities,and unsafe or unapproved drugs.”
The potential health consequences of using these counterfeit drugs are severe. The FBI warns that the health risks of taking the “misrepresented drugs” include a range of serious conditions, “everything from cardiac and gastrointestinal disorders to nervous system disorders, psychiatric disorders and death.”
Sources of Counterfeit Drugs
The agency has identified that these fraudulent drugs are being sold by “noncompliant healthcare providers” including weight loss clinics, pharmacies, and medical spas. Consumers should exercise extreme caution when obtaining weight loss medications from these sources.
Case Exmaple: Animal-Grade Semaglutide
In one specific instance, the FBI reported that a medical spa and weight loss clinic located in the South was selling its own compounded weight loss medication. This medication was found to contain animal-grade semaglutide combined with vitamin B12, failing to meet the stringent regulations set by the U.S. Food and Drug Administration.
How to Protect Yourself
The FBI advises consumers to be vigilant and avoid “suspiciously low prices” for weight loss drugs, especially when offered by unlicensed healthcare providers. It is indeed crucial to purchase medications only from licensed pharmacies to ensure their safety and authenticity.
Key Recommendations:
- Avoid Suspiciously Low Prices: Be wary of deals that seem too good to be true.
- Purchase from Licensed Pharmacies: Ensure the pharmacy is legitimate and licensed.
- Consult a Medical Provider: Seek professional medical advice before using any weight loss medications.
Compounded Drugs: What You Need to Know
Legitimate versions of compounded drugs are essentially copies of FDA-approved medications, produced by licensed pharmacies. Though, it’s critically important to note that these compounded drugs are not approved or inspected by the FDA.
Drug compounding is permitted under specific circumstances, such as when drugs are on the FDA’s shortage list or when a patient requires an option formulation due to an inability to take the standard version. It’s crucial to remember that compounded versions of semaglutide always require a prescription.
FDA Action on Shortages and Compounding
The surge in popularity of weight loss medications in recent years led to drug shortages. The FDA has as declared these shortages “resolved,” removing drugs like Ozempic and Wegovy from its shortage list.
However, the FDA has also “announced” a timeline for restricting the production of most compounded versions of semaglutide. State-licensed pharmacies must cease making most compounded semaglutide (copies of Novo Nordisk’s Wegovy and Ozempic) by April 22, 2025, and larger outsourcing pharmacies by May 22, 2025, pending any court rulings.
Ozempic and Wegovy: Approved Uses
Ozempic is FDA-approved for treating Type 2 diabetes, but some doctors prescribe it “off-label” for weight loss, which is permissible under FDA regulations.
Wegovy, containing the same active ingredient as Ozempic (semaglutide), is specifically FDA-approved for weight loss in individuals with obesity or who are overweight with at least one weight-related condition. It is indeed also approved to reduce the risk of major cardiovascular events in adults with obesity or who are overweight with established cardiovascular disease.
How Semaglutide Works
Semaglutide functions by slowing down the movement of food through the stomach and curbing appetite, ultimately leading to weight loss.
Timeline of Restrictions on Compounded Semaglutide
| Date | Action |
|---|---|
| April 22, 2025 | State-licensed pharmacies must stop making most compounded semaglutide. |
| May 22, 2025 | Larger outsourcing pharmacies must stop making most compounded semaglutide. |
Counterfeit Semaglutide Weight Loss Drugs: what You Need to Know
Teh FBI has issued a warning about counterfeit weight loss drugs claiming to contain semaglutide, the active ingredient in Ozempic and Wegovy. This Q&A addresses common concerns and provides crucial information to protect yoru health.
Q&A: Counterfeit Semaglutide and Weight Loss Drugs
What is the FBI warning about counterfeit weight loss drugs?
The FBI is alerting the public to the dangers of counterfeit weight loss drugs that are being sold as legitimate medications containing semaglutide. These fraudulent drugs may contain:
Compounded mixtures of unkown drugs
Drugs that do not contain semaglutide at all
Drugs with high levels of impurities
unsafe or unapproved drugs
What are the health risks associated with counterfeit semaglutide drugs?
The FBI warns that the health risks associated with these misrepresented drugs can be severe, including:
Cardiac disorders
Gastrointestinal disorders
Nervous system disorders
Psychiatric disorders
Death
Were are these counterfeit drugs being sold?
The agency has identified that these fraudulent drugs are being sold by:
Noncompliant healthcare providers
Weight loss clinics
Pharmacies
medical spas
Consumers should exercise extreme caution when obtaining weight loss medications from these sources.
What is semaglutide, and what are Ozempic and Wegovy approved for?
Semaglutide is the active ingredient in Ozempic and Wegovy. It works by slowing down the movement of food through the stomach and reducing appetite, leading to weight loss.
Ozempic is FDA-approved for treating Type 2 diabetes, but doctors sometimes prescribe it “off-label” for weight loss.
Wegovy is specifically FDA-approved for weight loss in individuals with obesity or who are overweight with at least one weight-related condition. It’s also approved to reduce the risk of major cardiovascular events in adults with obesity or who are overweight with established cardiovascular disease.
What is “off-label” prescription?
“Off-label” prescription refers to when a doctor prescribes a medication for a condition other than the one for wich it has been officially approved by the FDA.This is legal and common, allowing doctors to tailor treatments to individual patient needs based on their professional judgment.
What is a compounded drug, and what should I know about compounded semaglutide?
Legitimate compounded drugs are copies of FDA-approved medications produced by licensed pharmacies. However, it’s crucial to remember that:
Compounded drugs are not approved or inspected by the FDA.
Drug compounding is permitted under specific circumstances, such as when drugs are on the FDA’s shortage list or when a patient requires an option formulation.
Compounded versions of semaglutide always require a prescription.
What has the FDA done regarding shortages and compounding of semaglutide drugs?
The FDA has declared that shortages of drugs like Ozempic and Wegovy are “resolved,” removing them from the shortage list.
The FDA has announced a timeline for restricting the production of most compounded versions of semaglutide: state-licensed pharmacies must cease making most compounded semaglutide by April 22, 2025, and larger outsourcing pharmacies by May 22, 2025, pending any court rulings.
How can I protect myself from counterfeit weight loss drugs?
The FBI advises consumers to:
Avoid Suspiciously Low Prices: Be wary of deals that seem too good to be true.
Purchase from Licensed Pharmacies: Ensure the pharmacy is legitimate and licensed.
Consult a Medical Provider: Seek professional medical advice before using any weight loss medications.
Case Example: What happened with the animal-grade semaglutide?
The FBI reported that a medical spa and weight loss clinic was selling its own compounded weight loss medication. This medication was found to contain animal-grade semaglutide combined with vitamin B12, failing to meet the stringent regulations set by the U.S. Food and Drug Governance.
Restrictions on Compounded Semaglutide
| Date | Action |
| :———— | :———————————————————————— |
| April 22, 2025 | State-licensed pharmacies must stop making most compounded semaglutide. |
| May 22, 2025 | Larger outsourcing pharmacies must stop making most compounded semaglutide. |
